NCT04356586

Brief Summary

Three hundred healthcare workers with mild symptoms for Covid-19 will be followed during three months. Each two weeks, serological tests will be performed. Re-infection will be monitored by saliva-swabs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
287

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 17, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 22, 2020

Completed
12 days until next milestone

Study Start

First participant enrolled

May 4, 2020

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 21, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 21, 2020

Completed
Last Updated

September 7, 2020

Status Verified

September 1, 2020

Enrollment Period

4 months

First QC Date

April 17, 2020

Last Update Submit

September 4, 2020

Conditions

COVID-19Serology

Outcome Measures

Primary Outcomes (2)

  • Percentage of serological positive healthcare workers

    three months

  • Percentage of HCW with positive Saliva-sabs

    three months

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

HCW previous tested for Covid-19 with mild symptoms in Jessa Ziekenhuis, Belgium

You may qualify if:

  • HCW previous tested for Covid-19 with mild symptoms in Jessa Ziekenhuis, Belgium

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sciensano

Brussels, 1050, Belgium

Location

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Maria Goossens, MD, PhD

    Sciensano

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Months
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Scientific collaborator

Study Record Dates

First Submitted

April 17, 2020

First Posted

April 22, 2020

Study Start

May 4, 2020

Primary Completion

August 21, 2020

Study Completion

August 21, 2020

Last Updated

September 7, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share

Locations

BE(1)